Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factor-κB pathway

Cancer Research

Volumn 65, Issue 18, 2005, Pages 8558-8566

  Berchtold, Craig M ^a   Chen, Kai Shun ^a,b   Miyamoto, Shigeki ^a   Gould, Michael N ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIMONENE; METHANOL; PERILLIC ACID; PERILLYL ALCOHOL; TERPENE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER; CANCER CELL CULTURE; CELL KILLING; CELL STRAIN MCF 7; CELL SURVIVAL; CULTURE MEDIUM; DRUG EFFECT; DRUG STRUCTURE; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELL LINE, TUMOR; HUMANS; LYMPHOMA, B-CELL; MONOTERPENES; NF-KAPPA B;

EID: 24944497137     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4072     Document Type: Article

References (49)

1. Gould MN. Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect 1997;105:977-9.
2. Ariazi EA, Satomi Y, Ellis MJ, et al. Activation of the TGF-β signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. Cancer Res 1999;59:1917-28.
3. Karin M, Hunter T. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol 1995;5:747-57.
4. Hawthorn M, Ferrante J, Luchowski E, et al. The actions of peppermint oil and menthol on calcium channel dependent processes in intestinal, neuronal and cardiac preparations. Aliment Pharmacol Ther 1988;2:101-18.
5. Ripple GH, Gould MN, Stewart JA, et al. Phase I clinical trial of perillyl alcohol administered daily. Clin Cancer Res 1998;4:1159-64.
6. Mascher H, Kikuta C, Schiel H. Pharmacokinetics of menthol and carvone after administration of an enteric coated formulation containing peppermint oil and caraway oil. Arzneimittelforschung 2001;51:465-9.
7. Vaughan TL, Farrow DC, Hansten PD, et al. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomarkers Prev 1998;7:749-56.
8. Kenakin T. Drugs and receptors. An overview of the current state of knowledge. Drugs 1990;40:666-87.
9. Lukes RJ, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer 1974;34 Suppl:1488-503.
10. Sadighi Akha AA, Willmott NJ, Brickley K, Dolphin AC, Galione A, Hunt SV. Anti-Ig-induced calcium influx in rat B lymphocytes mediated by cGMP through a dihydropyridine-sensitive channel. J Biol Chem 1996;271:7297-300.
11. Savignac M, Badou A, Moreau M, et al. Protein kinase C-mediated calcium entry dependent upon dihydropyridine-sensitive channels: a T cell receptor-coupled signaling pathway involved in IL-4 synthesis. FASEB J 2001;15:1577-9.
12. Miyamoto S, Seufzer BJ, Shumway SD. Novel IκBα proteolytic pathway in WEHI-231 immature B cells. Mol Cell Biol 1998;18:19-29.
13. Wu M, Lee H, Bellas RE, et al. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 1996;15:4682-90.
14. Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 2001;294:333-9.
15. Shumway SD, Berchtold CM, Gould MN, Miyamoto S. Evidence for unique calmodulin-dependent NF-κB regulation in WEHI-231 B cells. Mol Pharmacol 2002;61:177-85.
16. Zamai L, Falcieri E, Marhefka G, Vitale M. Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation. Cytometry 1996;23:303-11.
17. Hirsch T, Marchetti P, Susin SA, et al. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997;15:1573-81.
18. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJ. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989;337:181-4.
19. Eastman A. Assays for DNA fragmentation, endonucleases, and intracellular pH and calcium associated with apoptosis. Methods Cell Biol 1995;46:41-55.
20. Kao JP. Practical aspects of measuring calcium with fluorescent indicators. Methods Cell Biol 1994;40:155-81.
21. Kaspar RL, Kakegawa T, Cranston H, Morris DR, White MW. A regulatory cis element and a specific binding factor involved in the mitogenic control of murine ribosomal protein L32 translation. J Biol Chem 1992;267:508-14.
22. Perez-Reyes E, Wei XY, Castellano A, Birnbaumer L. Molecular diversity of L-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes. J Biol Chem 1990;265:20430-6.
23. Agoston A, Kunz L, Krieger A, Mayerhofer A. Two types of calcium channels in human ovarian endocrine cells: involvement in steroidogenesis. J Clin Endocrinol Metab 2004;89:4503-12.
24. Heubach JF, Graf EM, Leutheuser J, et al. Electrophysiological properties of human mesenchymal stem cells. J Physiol 2004;554:659-72.
25. Miyamoto S, Schmitt MJ, Verma IM. Qualitative changes in the subunit composition of κB-binding complexes during murine B cell differentiation. Proc Natl Acad Sci U S A 1994;91:5056-60.
26. Huang TT, Wuerzberger-Davis SM, Seufzer BJ, et al. NF-κB activation by camptothecin: a linkage between nuclear DNA damage and cytoplasmic signaling events. J Biol Chem 2000;275:9501-9.
27. Lernbecher T, Muller U, Wirth T. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 1993;365:767-70.
28. Feldhaus AL, Klug CA, Arvin KL, Singh H. Targeted disruption of the Oct-2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element-mediated gene activation. EMBO J 1993;12:2763-72.
29. Fitzgerald K, Harrington A, Leder P. Ras pathway signals are required for notch-mediated oncogenesis. Oncogene 2000;19:4191-8.
30. Wang CY, Guttridge DC, Mayo MW, Baldwin AS. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 1999;19:5923-9.
31. Chiao PJ, Miyamoto S, Verma IM. Autoregulation of IκBα activity. Proc Natl Acad Sci U S A 1994;91:28-32.
32. Schauer SL, Wang Z, Sonenshein GE, Rothstein TL. Maintenance of NF-κB/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of IκBα. J Immunol 1996;157:81-6.
33. Sutherland CL, Krebs DL, Gold MR. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of IκBα, and protection of WEHI-231 cells from anti-IgM-induced growth arrest. J Immunol 1999;162:4720-30.
34. Hockerman GH, Peterson BZ, Johnson BD, Catterall WA. Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol 1997;37:361-96.
35. Berchtold CM, Ariazi EA, Gould MN. Perillyl alcohol mediated induction of apoptosis in human breast cancer cells in vitro. Proc Annu Meet Am Assoc Cancer Res 2000;40:487.
36. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Sledge GW. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997;17:3629-39.
37. Mitterdorfer J, Grabner M, Kraus RL, et al. Molecular basis of drug interaction with L-type calcium channels. J Bioenerg Biomembr 1998;30:319-34.
38. Griffin S, Wyllie SG, Markham J. Determination of octanol-water partition coefficient for terpenoids using reversed-phase high-performance liquid chromatography. J Chromatogr A 1999;864:221-8.
39. Ferry DR, Goll A, Glossmann H. Putative calcium channel molecular weight determination by target size analysis. Naunyn Schmiedebergs Arch Pharmacol 1983;323:292-7.
40. Porter GA, Makuck RF, Rivkees SA. Reduction in intracellular calcium levels inhibits myoblast differentiation. J Biol Chem 2002;277:28942-7.
41. Kotturi MF, Carlow DA, Lee JC, Ziltener HJ, Jefferies WA. Identification and functional characterization of voltage-dependent calcium channels in T lymphocytes. J Biol Chem 2003;278:46949-60.
42. Crowell PL, Chang RR, Ren ZB, Elson CE, Gould MN. Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen D-limonene and its metabolites. J Biol Chem 1991;266:17679-5.
43. Crowell PL, Ren Z, Lin S, Vedejs E, Gould MN. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol 1994;47:1405-15.
44. Shi W, Gould MN. Induction of cytostasis in mammary carcinoma cells treated with the anticancer agent perillyl alcohol. Carcinogenesis 2002;23:131-42.
45. Ariazi EA, Gould MN. Identifying differential gene expression in monoterpene-treated mammary carcinomas using subtractive display. J Biol Chem 1996;271:29286-94.
46. Fields ER, Seufzer BJ, Oltz EM, Miyamoto SA. Switch in distinct IκBα degradation mechanisms mediates constitutive NF-κB activation in mature B cells. J Immunol 2000;164:4762-7.
47. O'Connor S, Shumway SD, Amanna IJ, Hayes CE, Miyamoto S. Regulation of constitutive p50/c-rel activity via proteasome inhibitor-resistant IκBα degradation in B cells. Mol Cell Biol 2004;24:4895-908.
48. Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκBα that can be inhibited by the tumor suppressor PTEN. Oncogene 2001;20:1287-99.
49. Aggarwal BB. NF-κB: The enemy within. Cancer Cell 2004;6:203-28.